Lazard Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Lazard Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,707	Closed	-$614K	–	2146
2021 Q1	$614K	Sell	7,707 -20,552	-73%	-$1.6M	﹤0.01%	955
2020 Q4	$2.23M	Buy	+28,259	New	+$1.66M	﹤0.01%	778
2019 Q4	–	Sell	-129	Closed	-$9K	–	1715
2019 Q3	$9K	Buy	+129	New	+$10.9K	﹤0.01%	1323

Lazard Asset Management's CMD Position: Q2 2021 in Review

Lazard Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 7,707 shares — an estimated $614K sold.

Lazard Asset Management first reported a position in CMD in Q3 2019 and held it in 3 quarters. The position peaked at $2.23M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Lazard Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Lazard Asset Management sold 7,707 Cantel Medical Corporation shares in Q2 2021, an estimated $614K.
Lazard Asset Management first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 3 quarters.
Lazard Asset Management's Cantel Medical Corporation position peaked at $2.23M in Q4 2020.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Lazard Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.